Flumist
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
2815 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Human influenza | D007251 | EFO_0007328 | J11.1 | 431 | 538 | 449 | 350 | 642 | 2258 |
| Covid-19 | D000086382 | — | U07.1 | 14 | 20 | 21 | 11 | 107 | 165 |
| Infections | D007239 | EFO_0000544 | — | 12 | 42 | 31 | 12 | 73 | 163 |
| Respiratory tract infections | D012141 | — | J06.9 | 9 | 19 | 26 | 10 | 69 | 127 |
| Communicable diseases | D003141 | — | — | 9 | 33 | 25 | 11 | 50 | 123 |
| Virus diseases | D014777 | — | B34 | 24 | 28 | 31 | 10 | 35 | 122 |
| Healthy volunteers/patients | — | — | — | 48 | 29 | 21 | 20 | 17 | 122 |
| Influenza in birds | D005585 | — | J09.X | 61 | 49 | 9 | 1 | 9 | 113 |
| H1n1 subtype influenza a virus | D053118 | — | — | 4 | 15 | 8 | 6 | 23 | 54 |
| Pneumonia | D011014 | EFO_0003106 | J18 | 4 | 3 | 8 | 8 | 30 | 52 |
Show 143 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sars-cov-2 | D000086402 | — | — | 5 | 6 | 2 | — | 9 | 19 |
| Respiratory syncytial viruses | D012136 | — | — | 5 | 1 | 3 | — | 10 | 19 |
| Rna virus infections | D012327 | — | — | 4 | 8 | 4 | — | 4 | 19 |
| Tetanus | D013742 | EFO_0005593 | A35 | — | 2 | 11 | — | 3 | 15 |
| Diphtheria | D004165 | EFO_0005549 | A36 | — | — | 10 | — | 4 | 14 |
| Immunization | D007114 | — | — | 1 | — | 2 | — | 10 | 13 |
| Respiratory distress syndrome | D012128 | EFO_1000637 | J80 | 4 | 1 | 2 | — | 7 | 13 |
| Infectious myxomatosis | D009234 | EFO_0007327 | — | — | 8 | 4 | — | — | 12 |
| Lymphoma | D008223 | — | C85.9 | 1 | 3 | 1 | — | 6 | 11 |
| Poliomyelitis | D011051 | EFO_0007450 | A80 | — | 1 | 10 | — | 1 | 11 |
Show 57 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 4 | 4 | — | — | 5 | 12 |
| Viral pneumonia | D011024 | EFO_0007541 | J12.9 | — | 1 | — | — | 9 | 10 |
| H7n9 subtype influenza a virus | D064766 | — | — | 8 | 2 | — | — | 1 | 10 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 1 | 4 | — | — | 2 | 6 |
| Lymphoid leukemia | D007945 | — | C91 | 2 | 2 | — | — | 2 | 6 |
| Immunocompromised host | D016867 | — | D84.9 | — | 3 | — | — | 3 | 6 |
| Vaccine-preventable diseases | D000079263 | — | — | — | 1 | — | — | 5 | 6 |
| Colorectal neoplasms | D015179 | — | — | 1 | 2 | — | — | 3 | 6 |
| Myelodysplastic syndromes | D009190 | — | D46 | 1 | 1 | — | — | 3 | 5 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | 1 | — | — | 3 | 5 |
Show 52 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Acute lung injury | D055371 | EFO_0004610 | — | 2 | — | — | — | 5 | 7 |
| Newborn respiratory distress syndrome | D012127 | — | P22 | 2 | — | — | — | 2 | 4 |
| Central nervous system neoplasms | D016543 | — | — | 1 | — | — | — | 2 | 3 |
| Nervous system neoplasms | D009423 | — | — | 1 | — | — | — | 2 | 3 |
| Non-small-cell lung carcinoma | D002289 | — | — | 1 | — | — | — | 1 | 2 |
| Squamous cell carcinoma | D002294 | — | — | 2 | — | — | — | — | 2 |
| Squamous cell neoplasms | D018307 | — | — | 2 | — | — | — | — | 2 |
| Head and neck neoplasms | D006258 | — | — | 2 | — | — | — | — | 2 |
| Atopic dermatitis | D003876 | EFO_0000274 | L20 | 1 | — | — | — | 1 | 2 |
| Dermatitis | D003872 | — | L30.9 | 1 | — | — | — | 1 | 2 |
Show 15 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Emergencies | D004630 | — | — | — | — | — | — | 11 | 11 |
| Health behavior | D015438 | — | — | — | — | — | — | 10 | 10 |
| Vaccination hesitancy | D000088823 | — | — | — | — | — | — | 9 | 9 |
| Invasive pulmonary aspergillosis | D055744 | — | B44.0 | — | — | — | — | 8 | 8 |
| Sepsis | D018805 | EFO_0001420 | A41.9 | — | — | — | — | 7 | 7 |
| Vaccination refusal | D000072758 | — | — | — | — | — | — | 6 | 6 |
| Risk reduction behavior | D040242 | — | — | — | — | — | — | 5 | 5 |
| Pulmonary aspergillosis | D055732 | EFO_1001834 | — | — | — | — | — | 5 | 5 |
| Otitis media | D010033 | EFO_0004992 | H66.9 | — | — | — | — | 4 | 4 |
| Toxemia | D014115 | — | — | — | — | — | — | 4 | 4 |
Show 223 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Flumist – AstraZeneca
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
356 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use